10.2 Fluid Requirements & Electrolyte Management

10.2 Fluid Requirements & Electrolyte Management

Neonatal fluid and electrolyte management requires an intimate understanding of developmental renal physiology, body water compartment shifts, and environmental evaporative dynamics. The transition from intrauterine aqueous life to extrauterine terrestrial existence involves a profound reorganization of fluid balance. Failure to anticipate these physiological changes can lead to severe dehydration, hyperosmolality, acute renal failure, or fluid overload complications including patent ductus arteriosus (PDA), bronchopulmonary dysplasia (BPD), and necrotizing enterocolitis (NEC).

---

1. Body Water Distribution & Postnatal Fluid Physiology

At birth, the human neonate is composed predominantly of water. Total Body Water (TBW) and its compartmental distribution change dramatically as gestational age advances:

+---------------------------------------------------------------------------------------------------------+
|                               TOTAL BODY WATER (TBW) COMPARTMENT DYNAMICS                               |
|                                                                                                         |
|   [Extremely Preterm (<28 wks)]  -->  TBW = 85–90% Body Weight  (ECF: ~65%  |  ICF: ~25%)               |
|   [Term Newborn (40 wks)]        -->  TBW = 75–80% Body Weight  (ECF: ~45%  |  ICF: ~35%)               |
|   [Adult Comparison]             -->  TBW = 55–60% Body Weight  (ECF: ~20%  |  ICF: ~40%)               |
+---------------------------------------------------------------------------------------------------------+

The Three Postnatal Fluid Adaptation Phases

1. Phase I: Pre-Diuretic Phase (First 24 to 48 Hours of Life):
   • Characterized by low Glomerular Filtration Rate (GFR: ~15–20 mL/min/1.73m² in term, even lower in preterm), high renal vascular resistance, and low urine output (0.5 to 1.5 mL/kg/hour).
   • Fluid intake is intentionally restricted to prevent intravascular volume overload.
   • Electrolytes (Sodium and Potassium) are withheld from intravenous fluids during this initial phase.
2. Phase II: Diuretic Phase (Days 2 to 4–5 Postpartum):
   • Characterized by a spontaneous, physiologic increase in GFR, marked natriuresis (urinary sodium excretion), and a sharp rise in urine output (2.0 to 4.0 mL/kg/hour).
   • This diuresis reflects the normal physiological contraction of the expanded Extracellular Fluid (ECF) volume.
   • Sodium and potassium supplementation is initiated once spontaneous diuresis is established.
3. Phase III: Post-Diuretic / Stable Growth Phase (Day 5–7 Onward):
   • ECF contraction is complete. Body weight stabilizes and begins to increase by 15 to 30 g/day in term and growing preterm infants, driven by positive caloric and nitrogen balance.

Expected Physiologic Weight Loss & Clinical Alert Limits

• Term Neonates: Normal weight loss is 5% to 10% of birth weight, reaching a nadir on Days 3 to 5 of life. Birth weight should be regained by 10 to 14 days of life.
• Preterm / VLBW Neonates: Normal weight loss is 10% to 15% of birth weight, reaching a nadir on Days 5 to 7 of life. Birth weight is typically regained by 14 to 21 days of life.
• Clinical Alert Thresholds:
  • Excessive Weight Loss (>10% term or >15% preterm): Indicates excessive dehydration, high insensible water loss (TEWL), inadequate fluid intake, or osmotic diuresis.
  • Inadequate Weight Loss (<5% in first 4 days) or Immediate Weight Gain: Signals delayed diuresis and fluid overload. Excess ECF expansion is strongly associated with an increased incidence of hemodynamically significant PDA, pulmonary edema, BPD, and NEC.

2. Transitional Daily Fluid Calculations & Environmental Adjustments

Daily intravenous fluid requirements must be calculated using the infant's birth weight (or current weight, whichever is lower during the first week) and adjusted based on environmental exposures and clinical conditions.

Day-by-Day Transitional Fluid Requirements

Clinical & Environmental Fluid Adjustments

• Phototherapy (Conventional or LED/Fiberoptic): Add +10 to +20 mL/kg/day to compensate for increased peripheral blood flow, radiant warming, and watery stool losses.
• Radiant Warmer (Open Bed): Add +10 to +20 mL/kg/day due to elevated transepidermal convective/radiant evaporative losses compared to enclosed incubators.
• Fever / Elevated Core Temperature: Add +10 mL/kg/day for every 1.0°C elevation above 37.5°C.
• High Incubator Humidity (70%–85%): Reduce baseline fluid requirements by 20 to 30 mL/kg/day because high ambient vapor pressure dramatically suppresses TEWL.
• Fluid Restriction Conditions (40 to 60 mL/kg/day):
  • Hypoxic-Ischemic Encephalopathy (HIE) / Therapeutic Hypothermia: Acute tubular necrosis and high SIADH risk; strict fluid restriction (40–50 mL/kg/day) prevents cerebral and pulmonary edema.
  • Syndrome of Inappropriate Antidiuretic Hormone (SIADH): Oliguria, low serum sodium (<130 mEq/L) with inappropriately concentrated urine.
  • Acute Renal Failure (Oliguric / Anuric AKI): Restrict fluid to insensible water loss (30–40 mL/kg/d) plus urine output replacement.

---

3. Insensible Water Loss (IWL) & Transepidermal Dynamics

Insensible Water Loss (IWL) is water lost via vaporization that cannot be directly measured. It consists of two components:

1. Transepidermal Water Loss (TEWL: ~70% of total IWL): Evaporation of water directly through the skin.
2. Respiratory Water Loss (~30% of total IWL): Evaporation of moisture from the mucosal surfaces of the respiratory tract during exhalation.

TEWL Across Gestational Age

• In term infants, IWL averages 30 to 60 mL/kg/day.
• In extremely low birth weight (ELBW: <1,000 g) infants, TEWL can exceed 100 to 150 mL/kg/day during the first days of life due to an ultra-thin stratum corneum, high cutaneous vascularity, and large surface area-to-weight ratio. Unmitigated TEWL leads to rapid dehydration, hypernatremic hyperosmolality, and severe hypothermia.

Environmental Strategies to Suppress TEWL

• Humidified Double-Walled Incubators: Maintain 70% to 85% relative humidity for infants <32 weeks gestation during the first 7 to 14 days of life, then wean gradually to 50% as the stratum corneum matures.
• Polyethylene Occlusive Wrap: Applied immediately at delivery from the neck down without drying for infants <32 weeks.
• Heated Humidified Ventilator Circuits: Deliver respiratory gases at 37°C with 100% relative humidity (44 mg H₂O/L).

---

4. Electrolyte Homeostasis & Clinical Derangements

1. Sodium ($Na^+$) Balance (Normal Range: 135 to 145 mEq/L)

• Physiology & Maintenance: Sodium is the principal extracellular cation determining serum osmolality ($Osm \approx 2 \times [Na^+] + \text{Glucose}/18 + \text{BUN}/2.8$). Maintenance requirements are 2 to 4 mEq/kg/day in term infants and 3 to 5 mEq/kg/day in preterm infants (preterm neonates have immature proximal renal tubules with low expression of Na+/K+-ATPase pumps, resulting in fractional excretion of sodium [$FE_{Na}$] up to 5% vs <1% in term).
• Timing: Sodium must be withheld on Day 1 and added only after spontaneous diuresis begins (Day 2–3).

+---------------------------------------------------------------------------------------------------------+
|                                 HYPONATREMIA (<135 mEq/L) DIFFERENTIAL MATRIX                           |
|                                                                                                         |
|   [Dilutional Hyponatremia (Hypervolemic)]  --> Excess free water, SIADH, fluid overload                |
|   * Physical Exam: Edema, rapid weight gain, full fontanelle, low/normal urine output                   |
|   * Treatment: FLUID RESTRICTION (40–60 mL/kg/day); do NOT administer hypertonic saline                |
|                                                                                                         |
|   [Depletional Hyponatremia (Hypovolemic)]  --> Inadequate Na+ intake, renal Na+ wasting, loop diuretics|
|   * Physical Exam: Weight loss >10–15%, dry mucosa, sunken fontanelle, high urine output                |
|   * Treatment: SODIUM REPLACEMENT (increase IV NaCl to 4–6 mEq/kg/day) and isotonic volume repletion    |
+---------------------------------------------------------------------------------------------------------+

• Hypernatremia (>145 mEq/L):
  • Etiology: High TEWL (radiant warmers/unhumidified incubators), inadequate free water intake, lactation failure hypernatremic dehydration, excessive sodium bicarbonate boluses.
  • Pathophysiology: High ECF osmolality draws water out of brain cells $\rightarrow$ intracellular cerebral dehydration $\rightarrow$ brain shrinkage $\rightarrow$ traction and tearing of fragile dural bridging veins $\rightarrow$ subdural and subarachnoid hemorrhage, venous sinus thrombosis, and seizures.
  • CRITICAL CORRECTION RULE: Correct hypernatremia SLOWLY at a rate ≤ 0.5 mEq/L/hour or ≤ 10 to 12 mEq/L per 24 hours using hypotonic solutions (e.g., D5W with 0.2% NaCl). Rapid correction causes water to rush into hyperosmolar brain cells, precipitating fatal cerebral edema, brain herniation, and intractable seizures.

2. Potassium ($K^+$) Balance (Normal Range: 3.5 to 5.5 mEq/L; up to 6.0 in ELBW)

• Maintenance: 1 to 2 mEq/kg/day. NEVER add potassium to intravenous fluids until spontaneous urine output (> 1.0 mL/kg/hour) and adequate renal function are verified.
• Hyperkalemia (>6.5 mEq/L):
  • Etiology: Acute kidney injury, non-oliguric hyperkalemia of prematurity (shift of intracellular K+ to ECF in ELBW infants due to immature Na+/K+-ATPase pumps), massive hemolysis (cephalohematoma, subgaleal hemorrhage, Rh incompatibility), severe metabolic acidosis, rapid rewarming.
  • Note: Rule out pseudohyperkalemia from heel-stick hemolysis by drawing a free-flowing venous or arterial sample.
  • Progressive ECG Manifestations:
    1. Tall, peaked, symmetrical T waves with a narrow base ("tented" T waves).
    2. Prolonged PR interval and flattening/loss of P waves.
    3. Widening of the QRS complex and intraventricular conduction delays.
    4. Sine wave appearance (fusion of wide QRS and T wave).
    5. Ventricular tachycardia, ventricular fibrillation, and asystolic arrest.
  • Emergency Management Protocol (The 3 Steps):
    1. Myocardial Membrane Stabilization: 10% Calcium Gluconate 100 to 200 mg/kg (1.0 to 2.0 mL/kg) IV slow over 5 to 10 minutes with continuous ECG monitoring. Antagonizes membrane toxicity by restoring normal cardiac resting membrane potential threshold. Does not lower serum potassium.
    2. Intracellular Potassium Shifting:
       • Regular Insulin (0.1 units/kg IV) combined with D10W (2 mL/kg IV mini-bolus) followed by continuous D10W infusion to maintain normoglycemia.
       • Nebulized Inhaled Albuterol (0.4 mg in 2 mL saline): Beta-2 adrenergic stimulation drives K+ into cells.
       • Sodium Bicarbonate (1 to 2 mEq/kg IV slow over 10–20 min): ONLY if concurrent metabolic acidosis is present.
    3. Elimination & Removal:
       • Furosemide (1.0 mg/kg IV): Promotes renal excretion (if renal output present).
       • Sodium Polystyrene Sulfonate (Kayexalate 1.0 g/kg PR): Cation-exchange resin. WARNING: NEVER administer with sorbitol in neonates due to high risk of colonic necrosis and perforation.
       • Double-Volume Exchange Transfusion or Peritoneal Dialysis: For refractory life-threatening hyperkalemia.

3. Calcium ($Ca^{2+}$) Balance (Normal: Total 8.5–10.5 mg/dL; Ionized 4.4–5.4 mg/dL [1.1–1.35 mmol/L])

• Hypocalcemia Definition: Total calcium < 7.0 mg/dL in preterm, < 8.0 mg/dL in term, or Ionized Calcium ($iCa$) < 1.0 mmol/L (< 4.0 mg/dL).
• Early-Onset Hypocalcemia (<72 Hours): Seen in preterm infants (premature loss of placental transfer), Infants of Diabetic Mothers (IDM, due to maternal hypomagnesemia suppressing fetal PTH), and perinatal asphyxia (calcitonin release and tissue phosphate release).
• Late-Onset Hypocalcemia (>72 Hours): High-phosphate cow's milk formula (excess phosphorus binds calcium), hypoparathyroidism (DiGeorge syndrome / 22q11.2 deletion), maternal hyperparathyroidism, hypomagnesemia.
• Clinical Manifestations: Neuromuscular excitability, high-pitched cry, hyperreflexia, coarse jitteriness/tremors (stops with passive flexion), muscle twitching, laryngospasm, prolonged QTc interval on ECG (>0.44 seconds), and seizures.
• Emergency Treatment: 10% Calcium Gluconate 100 to 200 mg/kg (1.0 to 2.0 mL/kg) IV slow over 10 to 30 minutes with continuous ECG monitoring (stop infusion immediately for bradycardia or dysrhythmias). Ensure patent IV line: peripheral extravasation causes severe chemical cellulitis and tissue necrosis.

4. Magnesium ($Mg^{2+}$) Balance (Normal Range: 1.5 to 2.5 mg/dL [0.6 to 1.0 mmol/L])

• Hypomagnesemia (<1.5 mg/dL): Impairs PTH secretion and causes end-organ resistance. Refractory hypocalcemia will not correct until hypomagnesemia is treated with 50% Magnesium Sulfate (25 to 50 mg/kg IV/IM slow).
• Hypermagnesemia (>2.5 mg/dL): Seen after maternal antepartum $MgSO_4$ therapy. Manifests as generalized hypotonia, respiratory depression, lethargy, weak suck, delayed meconium passage, and hyporeflexia. Treatment is supportive (hydration, mechanical ventilation if needed); IV Calcium Gluconate acts as a direct physiological antagonist.